Cargando…
Pharmacotherapy for the Treatment of Smokeless Tobacco users
BACKGROUND: Pharmacotherapies have been shown to increase tobacco abstinence rates among smokeless tobacco (ST) users. Bupropion SR has demonstrated potential efficacy for ST users in pilot studies. We conducted a randomized, clinical trial to assess the efficacy and safety of bupropion SR for tobac...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129318/ http://dx.doi.org/10.4103/0019-5545.341549 |